CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
CALGB 40603(联盟):三阴性乳腺癌新辅助化疗联合或不联合卡铂和贝伐珠单抗治疗后的长期疗效及基因组相关性研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01506
Shepherd, Jonathan H; Ballman, Karla; Polley, Mei-Yin C; Campbell, Jordan D; Fan, Cheng; Selitsky, Sara; Fernandez-Martinez, Aranzazu; Parker, Joel S; Hoadley, Katherine A; Hu, Zhiyuan; Li, Yan; Soloway, Matthew G; Spears, Patricia A; Singh, Baljit; Tolaney, Sara M; Somlo, George; Port, Elisa R; Ma, Cynthia; Kuzma, Charles; Mamounas, Eleftherios; Golshan, Mehra; Bellon, Jennifer R; Collyar, Deborah; Hahn, Olwen M; Hudis, Clifford A; Winer, Eric P; Partridge, Ann; Hyslop, Terry; Carey, Lisa A; Perou, Charles M; Sikov, William M